Holen Sie sich die Stockscreener-App
189.85
2.22%
-4.32
Handel nachbörslich:
189.00
-0.85
-0.45%
Schlusskurs vom Vortag:
$194.17
Offen:
$194.87
24-Stunden-Volumen:
2.48M
Relative Volume:
1.07
Marktkapitalisierung:
$40.49B
Einnahmen:
$447.02M
Nettoeinkommen (Verlust:
$-1.18B
KGV:
-30.71
EPS:
-6.1812
Netto-Cashflow:
$-906.14M
1W Leistung:
-8.19%
1M Leistung:
-1.08%
6M Leistung:
+108.79%
1J Leistung:
+161.43%
1-Tages-Spanne:
$189.59
$197.50
1-Wochen-Bereich:
$189.59
$208.81
52-Wochen-Spanne:
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-04 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-28 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
TD Cowen raises Insmed stock price target to $269 on strong Brinsupri launch - Investing.com UK
Insmed (Nasdaq: INSM) highlights TPIP, brensocatib data in ERS 2025 ALERT session - Stock Titan
Resolute Capital Asset Partners LLC Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Hsbc Holdings PLC Has $1.30 Million Stake in Insmed, Inc. $INSM - MarketBeat
Hood River Capital Management LLC Reduces Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Holdings Decreased by Kennedy Capital Management LLC - MarketBeat
Guggenheim Capital LLC Acquires 5,945 Shares of Insmed, Inc. $INSM - MarketBeat
Jump Financial LLC Takes Position in Insmed, Inc. $INSM - MarketBeat
Bollard Group LLC Acquires New Holdings in Insmed, Inc. $INSM - MarketBeat
Marshall Wace LLP Acquires 417,124 Shares of Insmed, Inc. $INSM - MarketBeat
Quantbot Technologies LP Invests $2.22 Million in Insmed, Inc. $INSM - MarketBeat
Insmed (NASDAQ:INSM) Upgraded to "Strong-Buy" at Rothschild Redb - MarketBeat
Dir Sharoky Files To Sell 20,000 Of Insmed Inc [INSM] - TradingView
Is Insmed Stock Built to Withstand a Pullback? - Trefis
Insmed Insider Sold Shares Worth $2,199,915, According to a Recent SEC Filing - marketscreener.com
INSMED Chair and CEO William Lewis Sells Over 10,000 Shares - TradingView
Schroder Investment Management Group Reduces Position in Insmed, Inc. $INSM - MarketBeat
Diametric Capital LP Purchases Shares of 7,757 Insmed, Inc. $INSM - MarketBeat
Will Insmed Incorporated (IM8N) stock outperform small cap peersJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
How Insmed Incorporated (IM8N) stock compares with tech leadersMarket Trend Review & Safe Capital Preservation Plans - Newser
Will Insmed Incorporated stock see PE expansionJuly 2025 Highlights & Reliable Breakout Forecasts - Newser
Insmed reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Rothschild & Co Redburn Initiates Coverage on Insmed With Buy Rating, $263 Price Target - marketscreener.com
Panagora Asset Management Inc. Sells 157,126 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Prime Publishers, Inc.
Rothschild Redburn initiates Insmed stock with Buy rating, $263 target By Investing.com - Investing.com Canada
How Insmed Incorporated (IM8N) stock responds to job market shiftsOptions Play & Expert-Curated Trade Recommendations - Newser
Insmed Earnings Notes - Trefis
Insmed Insider Sold Shares Worth $1,841,101, According to a Recent SEC Filing - marketscreener.com
Norges Bank Takes Position in Insmed, Inc. $INSM - MarketBeat
State Board of Administration of Florida Retirement System Has $13.10 Million Stake in Insmed, Inc. $INSM - MarketBeat
Can Insmed Incorporated stock double in next 5 yearsJuly 2025 Recap & Daily Price Action Insights - Newser
Insmed (NASDAQ:INSM) Reaches New 1-Year HighShould You Buy? - MarketBeat
Is Insmed Incorporated (IM8N) stock positioned for digital growth eraInsider Selling & Consistent Profit Alerts - Newser
Has Insmed’s 988% Three Year Surge Already Priced In Its Growth Story? - simplywall.st
How Insmed Incorporated (IM8N) stock valuation compares with sectorWeekly Earnings Recap & Verified Short-Term Plans - Newser
New York State Common Retirement Fund Buys 72,031 Shares of Insmed, Inc. $INSM - MarketBeat
Mizuho Maintains Insmed (INSM) Outperform Recommendation - Nasdaq
INSM: Mizuho Raises Price Target, Maintains Outperform Rating | INSM Stock News - GuruFocus
Mizuho Raises Price Target on Insmed to $256 From $196, Keeps Outperform Rating - marketscreener.com
Mizuho raises Insmed stock price target to $256 on improved outlook - Investing.com Canada
Neuberger Berman Group LLC Has $1.10 Million Stock Position in Insmed, Inc. $INSM - MarketBeat
Russell Investments Group Ltd. Cuts Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Groupama Asset Managment - MarketBeat
Insmed, Inc. $INSM Position Lowered by Elevation Point Wealth Partners LLC - MarketBeat
Loomis Sayles & Co. L P Decreases Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Quadrature Capital Ltd Buys 89,217 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Insiders Sell US$54m Of Stock, Possibly Signalling Caution - Yahoo Finance
Northwest & Ethical Investments L.P. Has $488,000 Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Why Insmed Incorporated stock appeals to analystsJuly 2025 Update & Entry Point Confirmation Signals - BỘ NỘI VỤ
F m Investments LLC Trims Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.25%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):